ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 6 of 120 for:    Polycystic Kidney Disease

Lanreotide In Polycystic Kidney Disease Study (LIPS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02127437
Recruitment Status : Active, not recruiting
First Posted : April 30, 2014
Last Update Posted : December 21, 2017
Sponsor:
Collaborator:
IPSEN pharmaceutical company, Boulogne-Billancourt, France
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : September 2019
  Estimated Study Completion Date : September 2019